Skip to content

CGEN

Compugen Ltd.

NASDAQ · Healthcare · Biotechnology · IL

$2.59
+1.37%
Ask drillr
0
Insider buys (3m)
1
Insider sells (3m)
-$4.7K
Net value (3m)
+22.6%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 30, 2026Levine Zurit · officer: SVP, Business DevelopmentA-Award18,000$0.00
Jul 30, 2026Mahler Michelle · officer: Chief Medical OfficerA-Award18,000$2.26
Jul 30, 2026Mahler Michelle · officer: Chief Medical OfficerA-Award13,500$0.00
Jul 30, 2026ZWEIFACH SANFORD S · directorA-Award10,000$2.26
Jul 30, 2026ZWEIFACH SANFORD S · directorA-Award7,500$0.00
Jul 30, 2026Halevy Gilead · directorA-Award10,000$2.26
Jul 30, 2026Halevy Gilead · directorA-Award7,500$0.00
Jul 30, 2026Hukkelhoven Mathias · directorA-Award10,000$2.26
Jul 30, 2026Hukkelhoven Mathias · directorA-Award7,500$0.00
Jul 30, 2026Livnat Savitzky Kinneret · directorA-Award10,000$2.26
Jul 30, 2026Livnat Savitzky Kinneret · directorA-Award7,500$0.00
Jul 30, 2026Kredo Russo Sharon · officer: SVP, Research & DiscoveryA-Award24,000$2.26
Jul 30, 2026Kredo Russo Sharon · officer: SVP, Research & DiscoveryA-Award18,000$0.00
Jul 30, 2026Ferre Pierre · officer: Chief Operating OfficerA-Award70,000$4.00
Jul 30, 2026Perry Eran · directorA-Award10,000$2.26
Jul 30, 2026Perry Eran · directorA-Award7,500$0.00
Jul 30, 2026Cohen-Dayag Anat · directorA-Award100,000$2.26
Jul 30, 2026Ophir Eran · director, officer: President and CEOA-Award200,000$2.26
Jul 30, 2026Silberman David · officer: Chief Financial OfficerA-Award26,000$2.26
Jul 30, 2026Silberman David · officer: Chief Financial OfficerA-Award19,500$0.00
Jul 30, 2026Levine Zurit · officer: SVP, Business DevelopmentA-Award24,000$2.26
Jul 13, 2026Levine Zurit · officer: SVP, Business DevelopmentM-Exempt1,875$0.83
Jul 13, 2026Levine Zurit · officer: SVP, Business DevelopmentSale1,875$2.50
Apr 27, 2026Levine Zurit · officer: SVP, Business DevelopmentM-Exempt2,000$1.15
Apr 27, 2026Ophir Eran · director, officer: President and CEOSale5,000$3.20
Apr 27, 2026Ophir Eran · director, officer: President and CEOM-Exempt5,000$0.83
Apr 27, 2026Levine Zurit · officer: SVP, Business DevelopmentSale2,000$3.20
Apr 15, 2026Ophir Eran · director, officer: President and CEOSale5,000$2.90
Apr 15, 2026Levine Zurit · officer: SVP, Business DevelopmentSale2,000$2.80
Apr 15, 2026Levine Zurit · officer: SVP, Business DevelopmentM-Exempt2,000$1.15
Institutional positioning

13F filings over the trailing two quarters

New 13Increased 18Reduced 19Sold out 78
FilerActionSharesFiled
SILVERARC CAPITAL MANAGEMENT, LLCReduced3,315,845May 14, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased1,632,988May 14, 2026
MORGAN STANLEYReduced1,053,229May 15, 2026
ARK INVESTMENT MANAGEMENT LLCNew Position1,049,873May 12, 2026
MACQUARIE MANAGEMENT HOLDINGS, INC.Unchanged1,020,000May 15, 2026
TAYLOR FRIGON CAPITAL MANAGEMENT LLCReduced848,043Apr 29, 2026
NORTHERN TRUST CORPReduced650,868May 14, 2026
TWO SIGMA INVESTMENTS, LPIncreased521,587May 15, 2026
STATE STREET CORPIncreased415,366May 15, 2026
YELIN LAPIDOT HOLDINGS MANAGEMENT LTD.Unchanged318,852Apr 22, 2026
UBS GROUP AGReduced306,708May 5, 2026
DAFNA CAPITAL MANAGEMENT LLCReduced257,783May 15, 2026
MARSHALL WACE, LLPIncreased244,480May 15, 2026
CITADEL ADVISORS LLCIncreased182,593May 15, 2026
CITADEL ADVISORS LLCReduced173,026Sep 2, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 30, 2026